KEGG: ath:AT1G56610
UniGene: At.20575
At1g56610 is an F-box protein encoded in the Arabidopsis thaliana genome, identified in various phosphoproteomic studies. It contains the characteristic F-box domain that typically functions in protein-protein interactions, particularly as components of SCF (Skp1-Cullin-F-box) ubiquitin ligase complexes. These complexes play crucial roles in targeted protein degradation via the ubiquitin-proteasome pathway. The protein has been identified in phosphoproteomic analyses with a phosphorylation site characterized by the peptide sequence VFS(ph)QATLVTLK, with a regulation value of -0.73 under certain experimental conditions . The phosphorylation status of this protein may be important in regulating its activity, stability, or interactions with other proteins in signaling pathways.
The expression of At1g56610 varies across different tissues and developmental stages in Arabidopsis thaliana. To study its expression pattern, researchers commonly employ several methodologies:
Transcriptional analysis: RT-PCR and qPCR techniques using gene-specific primers to quantify mRNA expression levels across different tissues.
Promoter-reporter fusion: Creating transgenic plants with the At1g56610 promoter fused to reporter genes like GUS or fluorescent proteins to visualize tissue-specific expression patterns.
RNA-seq data analysis: Analyzing publicly available transcriptome datasets from resources like TAIR or NCBI GEO to compare expression levels across different tissues, developmental stages, and stress conditions.
Expression studies should include multiple biological replicates and appropriate statistical analysis to account for natural variation. When investigating tissue-specific expression, researchers should consider examining roots, shoots, leaves, flowers, and seeds at various developmental stages to create a comprehensive expression profile.
For successful recombinant expression of At1g56610, consider the following methodological approach:
Expression Systems Options:
| System | Advantages | Disadvantages | Best For |
|---|---|---|---|
| E. coli | Fast growth, high yield, inexpensive | May lack proper post-translational modifications | Initial structural studies, antibody production |
| Insect cells | Better post-translational modifications | More expensive, longer production time | Functional studies requiring proper folding |
| Plant expression systems | Native post-translational modifications | Lower yield, time-consuming | Interaction studies, in planta function |
When expressing At1g56610 in recombinant systems, researchers should first analyze the protein sequence for potential challenges such as codon bias, hydrophobic regions, and post-translational modifications. For bacterial expression, optimization may include using strains like BL21(DE3) with codon optimization and fusion tags (His, GST, MBP) to improve solubility. Temperature, IPTG concentration, and induction time should be optimized through small-scale expression trials before scaling up .
If bacterial expression proves challenging, consider using a glycoengineered mammalian cell line approach similar to that used for other recombinant proteins, which can provide proper glycosylation and phosphorylation patterns critical for protein function .
The phosphorylation of At1g56610 at the serine residue within the VFS(ph)QATLVTLK peptide can be verified through several complementary approaches:
Mass spectrometry analysis: Purify the protein from plant tissue or recombinant systems and perform LC-MS/MS analysis. Look specifically for the phosphorylated peptide VFS(ph)QATLVTLK identified in previous studies .
Phospho-specific antibodies: Generate antibodies against the phosphorylated peptide sequence for use in Western blotting or immunoprecipitation.
Phosphatase treatment assays: Treat purified protein with lambda phosphatase and compare migration patterns on SDS-PAGE or Phos-tag gels to determine if phosphorylation affects mobility.
Site-directed mutagenesis: Create serine-to-alanine (prevents phosphorylation) or serine-to-aspartate (phosphomimetic) mutations at the phosphorylation site to study functional consequences.
For mass spectrometry verification, employ enrichment strategies such as immobilized metal affinity chromatography (IMAC) or titanium dioxide (TiO₂) to concentrate phosphopeptides before analysis. Analysis should include both identification of the phosphorylation site and relative quantification compared to the non-phosphorylated form.
To identify the substrates of At1g56610 as part of an SCF complex, implement a multi-faceted experimental strategy:
Proximity-dependent biotin labeling: Express At1g56610 fused to BioID or TurboID in Arabidopsis cells, allowing biotinylation of proteins in close proximity. After affinity purification of biotinylated proteins, perform mass spectrometry to identify potential substrates.
Co-immunoprecipitation coupled with proteomics: Express epitope-tagged At1g56610 in Arabidopsis, perform immunoprecipitation under various conditions, and identify interacting proteins by mass spectrometry.
Yeast two-hybrid screens: Use At1g56610 as bait to screen Arabidopsis cDNA libraries for interacting proteins, with validation through secondary assays.
Substrate trapping: Create a dominant-negative version of the F-box protein by mutating critical residues or employ proteasome inhibitors to stabilize substrate interactions.
Comparative proteomics: Compare the proteome of wildtype plants with At1g56610 knockouts using SILAC or TMT labeling to identify proteins that accumulate in the absence of At1g56610-mediated degradation.
Validation of identified substrates should include confirming direct interaction, demonstrating ubiquitination in vitro and in vivo, and showing that substrate stability increases in plants lacking functional At1g56610. Additionally, examine if the regulatory value of -0.73 observed in phosphoproteomic studies affects substrate recognition.
The phosphorylation of At1g56610 at the VFS(ph)QATLVTLK site likely serves as a regulatory mechanism affecting protein function and interactions. To investigate this relationship:
Structural analysis: Create homology models of At1g56610 in phosphorylated and non-phosphorylated states to predict how phosphorylation might alter protein conformation. Consider using approaches similar to those used for modeling the AHK1-ED structure .
Phosphorylation-dependent interaction studies: Compare protein interactions of wild-type, phosphomimetic (S→D), and phospho-dead (S→A) versions of At1g56610 using techniques such as:
Co-immunoprecipitation with known SCF components
Yeast two-hybrid assays under different conditions
Surface plasmon resonance to measure binding kinetics
Functional complementation assays: Transform At1g56610 knockout plants with wild-type, phosphomimetic, and phospho-dead versions of At1g56610 to determine if phosphorylation status affects phenotypic rescue.
Phosphorylation dynamics: Analyze how different stresses or developmental stages affect At1g56610 phosphorylation using targeted phosphoproteomics.
Protein stability and localization: Determine if phosphorylation affects protein half-life, subcellular localization, or incorporation into SCF complexes.
To connect phosphorylation status with specific signaling pathways, consider analyzing At1g56610 phosphorylation in response to treatments such as 0.3M mannitol (10 minutes) or various hormonal treatments, following approaches similar to those used in other Arabidopsis phosphoproteomic studies.
To characterize the physiological role of At1g56610, comprehensive phenotypic analysis of genetic modification lines should include:
Methodological approach for phenotyping:
Generation of genetic material:
Create multiple independent knockout lines using CRISPR-Cas9 or T-DNA insertion
Develop overexpression lines using constitutive (35S) and inducible promoters
Generate complementation lines with wildtype, phosphomimetic, and phospho-dead versions
Growth and developmental phenotyping:
Stress response analysis:
Molecular phenotyping:
Transcriptome analysis of knockout vs. wildtype plants under normal and stress conditions
Proteomic profiling to identify accumulated proteins in knockout lines
Analysis of ubiquitination patterns in knockout vs. wildtype plants
When analyzing results, consider that F-box proteins often show subtle phenotypes due to functional redundancy. Statistical analysis should include multiple biological replicates and appropriate statistical tests to account for natural variation.
When faced with contradictory results in At1g56610 research, employ these methodological approaches to resolve discrepancies:
Experimental condition standardization: Carefully define and control experimental conditions, as minor variations can significantly impact results. Consider the following factors:
Growth conditions (temperature, light intensity, photoperiod)
Plant age and developmental stage
Media composition and pH
Treatment duration and intensity
For example, research has shown that temperature variations can significantly affect phenotypic outcomes in Arabidopsis mutants, as demonstrated in studies where temperature influenced hypocotyl elongation phenotypes .
Genetic background considerations:
Examine whether contradictory results come from different Arabidopsis ecotypes
Perform complementation tests to confirm phenotypes are due to the gene of interest
Create knockouts in multiple ecotypes to test background effects
Studies have shown that phenotypes can vary significantly between ecotypes like Ws-2, Nos-0, and Col-0 under identical conditions .
Methodological validation:
Employ multiple independent methods to test the same hypothesis
Validate antibody specificity and reagent quality
Utilize appropriate positive and negative controls
Statistical rigor:
Ensure sufficient biological and technical replicates
Apply appropriate statistical tests
Consider meta-analysis approaches when comparing across studies
Integration with systems biology:
Place contradictory results within the context of known regulatory networks
Consider compensatory mechanisms and functional redundancy
Use mathematical modeling to predict conditions under which different outcomes might occur
A systematic approach to resolving contradictions should consider that At1g56610 function may be highly context-dependent, similar to how AHK1 was found to act as a positive regulator of osmoregulation under specific defined conditions but showed variable results under different conditions .
To effectively study At1g56610 protein interactions in their native context:
In planta co-immunoprecipitation (Co-IP):
Express epitope-tagged At1g56610 (HA, FLAG, GFP) under native or inducible promoters
Perform Co-IP followed by Western blotting for suspected interactors
Scale up for Co-IP-MS to identify novel interactors
Consider crosslinking to stabilize transient interactions
Förster resonance energy transfer (FRET):
Create fusion proteins with appropriate fluorophore pairs (e.g., CFP-At1g56610 and YFP-interactor)
Measure FRET efficiency in different cellular compartments
Perform acceptor photobleaching FRET for quantitative measurements
Use in combination with bimolecular fluorescence complementation (BiFC)
Split luciferase complementation assay:
Fuse At1g56610 and potential interactor to complementary luciferase fragments
Measure reconstituted luciferase activity in intact plants
Monitor interactions dynamically in response to stimuli
Proximity labeling in planta:
Express At1g56610 fused to BioID2 or TurboID under native promoter
Perform biotin labeling in intact plants under various conditions
Identify biotinylated proteins through streptavidin pulldown and MS
Mating-based split-ubiquitin assay:
For subcellular localization studies, combine fluorescent protein tagging with co-localization studies using compartment markers, similar to approaches used for localizing AHK1-GFP and other fusion proteins . Time-course experiments capturing protein dynamics during stress responses or developmental transitions can provide valuable insights into the regulation of At1g56610 interactions.
When working with recombinant At1g56610, researchers frequently encounter these challenges and solutions:
Low expression levels:
Optimize codon usage for expression system
Test multiple fusion tags (His, GST, MBP, SUMO) to improve solubility
Screen expression conditions (temperature, induction time, media composition)
Consider glycoengineered cell lines for mammalian expression, similar to approaches used for other recombinant proteins
Protein insolubility:
Add solubilizing agents (low concentrations of urea, non-ionic detergents)
Express the protein as domains rather than full-length
Co-express with interacting partners or chaperones
Use refolding protocols if expression in inclusion bodies is unavoidable
Proteolytic degradation:
Add protease inhibitors throughout purification
Remove flexible linkers that may be susceptible to proteolysis
Optimize buffer conditions (pH, salt concentration, reducing agents)
Perform purification at 4°C and minimize handling time
Poor yield after purification:
Implement multiple purification steps (affinity, ion exchange, size exclusion)
Optimize elution conditions to maximize recovery
Test different buffer compositions for stability during storage
Consider batch purification instead of column chromatography for initial capture
Loss of functional activity:
Test activity immediately after purification
Identify stabilizing additives (glycerol, specific ions, reducing agents)
Store protein in small aliquots to avoid freeze-thaw cycles
Characterize post-translational modifications important for function
When troubleshooting, systematically test each variable while keeping others constant. Document all conditions and results carefully to identify patterns. Consider using recombinant expression platforms that maintain relevant post-translational modifications, particularly phosphorylation at the VFS(ph)QATLVTLK site .
Optimizing immunoprecipitation (IP) of At1g56610 requires attention to several critical parameters:
Antibody selection and validation:
Generate specific antibodies against unique epitopes of At1g56610
Validate antibody specificity using knockout lines as negative controls
Consider epitope-tagging (HA, FLAG, GFP) if specific antibodies are unavailable
Test antibody performance in Western blot before attempting IP
Cell lysis and extraction optimization:
Test multiple lysis buffers varying in detergent type and concentration (NP-40, Triton X-100, CHAPS)
Optimize salt concentration to maintain interactions while reducing non-specific binding
Include protease and phosphatase inhibitors to preserve protein integrity and modification status
Consider crosslinking for transient or weak interactions
IP conditions:
Determine optimal antibody-to-lysate ratio through titration experiments
Compare direct antibody conjugation to beads versus protein A/G approaches
Optimize incubation time and temperature (4°C overnight versus shorter room temperature incubations)
Test various washing stringencies to balance between maintaining interactions and reducing background
Controls and validation:
Always include negative controls (IgG, knockout plant extracts)
Perform reverse IP when possible to confirm interactions
Validate interactions through orthogonal methods (Y2H, FRET, BiFC)
Consider competition assays with excess peptide to demonstrate specificity
Specialized techniques for challenging interactions:
Use formaldehyde or DSP crosslinking for transient interactions
Employ proximity labeling approaches (BioID, APEX) as alternatives
Consider membrane-specific solubilization strategies if At1g56610 has membrane associations
Test two-step IP protocols for improved specificity in complex mixtures
When optimizing At1g56610 immunoprecipitation specifically, consider whether phosphorylation status affects interactions, and design experiments to capture both phosphorylated and non-phosphorylated forms, building on insights from previous phosphoproteomic studies .
For effective CRISPR/Cas9 editing of At1g56610, implement this comprehensive methodology:
Guide RNA design and validation:
Design multiple sgRNAs targeting early exons of At1g56610 using tools like CRISPOR or CHOPCHOP
Prioritize guides with high on-target and low off-target scores
Validate guide efficiency using in vitro cleavage assays before plant transformation
Consider targeting conserved domains critical for protein function
Vector construction and plant transformation:
Use a vector system allowing expression of both Cas9 and sgRNA
Consider egg cell-specific or meristem-specific promoters to increase germline editing
Transform using floral dip method and select primary transformants
Screen T1 plants for editing events using PCR and sequencing
Mutation screening and characterization:
Design PCR primers flanking the target site for amplification and sequencing
Use restriction enzyme digestion-based screening for rapid identification of edited plants
Perform TIDE analysis for mixed editing events
Sequence multiple clones to identify specific mutation types
Establishing homozygous knockout lines:
Self-pollinate edited T1 plants and screen T2 progeny
Identify homozygous mutants through sequencing
Confirm the absence of Cas9 transgene in selected lines
Validate protein knockout through Western blotting
Functional characterization:
Compare multiple independent knockout lines to control for off-target effects
Perform complementation with wild-type At1g56610 to confirm phenotypes
Create phospho-mutant variants (S→A and S→D) at the VFS(ph)QATLVTLK site
Analyze phenotypes under various conditions, including osmotic stress and temperature variations
Advanced editing strategies:
Consider base editing or prime editing for precise mutations without double-strand breaks
Use CRISPR interference (CRISPRi) for temporary knockdown studies
Implement conditional knockout systems (e.g., heat-inducible Cas9) to study essential genes
Create epitope-tagged versions using homology-directed repair
When analyzing CRISPR-generated At1g56610 mutants, evaluate phenotypes across multiple environmental conditions, as protein function may be context-dependent, similar to findings for other Arabidopsis proteins under varied temperatures and osmotic conditions .
For comprehensive RNA-seq analysis to identify At1g56610-regulated genes:
Experimental design considerations:
Compare At1g56610 knockout/knockdown lines with wild-type and complemented lines
Include multiple independent knockout lines to control for off-target effects
Consider time-course experiments following induction/repression of At1g56610
Design treatments that may trigger At1g56610 activity (osmotic stress, temperature changes)
Sample preparation and sequencing:
Extract RNA from developmentally matched tissues with sufficient biological replicates (minimum 3-4)
Verify RNA quality (RIN > 8) before library preparation
Sequence to adequate depth (30-50 million reads per sample) for differential expression analysis
Include spike-in controls for normalization
Primary data analysis pipeline:
Perform quality control using FastQC and adapter trimming if necessary
Align reads to Arabidopsis reference genome using STAR or HISAT2
Quantify gene expression using featureCounts or Salmon
Perform differential expression analysis using DESeq2 or edgeR
Advanced analytical approaches:
Conduct time-series analysis for temporal studies using maSigPro or ImpulseDE2
Perform gene set enrichment analysis (GSEA) to identify affected pathways
Use network analysis to identify co-regulated gene modules
Integrate with ChIP-seq data if available to distinguish direct from indirect targets
Validation and follow-up:
Confirm key differentially expressed genes with RT-qPCR
Cross-reference with proteomics data to identify post-transcriptional regulation
Conduct promoter analysis of regulated genes for common motifs
Test direct regulation using transient expression assays
For data interpretation, focus on genes showing consistent regulation across multiple knockout lines and experimental conditions. Pay particular attention to genes involved in protein degradation pathways, as F-box proteins typically function in targeted proteolysis. Consider how phosphorylation status (VFS(ph)QATLVTLK) might affect the regulatory network.
For rigorous analysis of phosphoproteomic data involving At1g56610:
Data preprocessing and quality control:
Normalize intensities using appropriate methods (global normalization, LOESS)
Handle missing values through imputation or specialized statistical methods
Assess technical and biological variation through coefficient of variation analysis
Filter low-quality phosphosites based on localization probability scores
Differential phosphorylation analysis:
Apply moderated t-tests with multiple testing correction (Benjamini-Hochberg)
Consider ANOVA for multi-condition comparisons
Implement linear models to account for batch effects and other covariates
Use specialized software (MaxQuant, Proteome Discoverer, Skyline) with appropriate statistical modules
Pathway and network analysis:
Conduct enrichment analysis specific to phosphorylation networks
Map phosphosites to known kinase motifs to identify responsible kinases
Integrate with protein-protein interaction networks
Perform causal network analysis to infer directionality of signaling
Time-course and dynamic phosphorylation analysis:
Apply clustering methods to identify co-regulated phosphosites
Use Gaussian process regression for temporal modeling
Implement principal component analysis to identify major patterns of variation
Consider partial least squares discriminant analysis for classification of phosphorylation patterns
Validation and interpretation:
When analyzing At1g56610 phosphorylation specifically, consider experimental designs similar to previous phosphoproteomic studies in Arabidopsis, such as the 10-minute treatment with 0.3M mannitol , to identify condition-specific phosphorylation patterns.
To effectively integrate multi-omics data for understanding At1g56610 function:
Data collection and harmonization:
Generate matched samples for transcriptomics, proteomics, phosphoproteomics, and metabolomics
Ensure consistent experimental conditions and timepoints across platforms
Include appropriate controls and sufficient biological replicates
Normalize and transform data to make different omics layers comparable
Multi-layer data integration approaches:
Correlation-based methods:
Calculate correlations between layers (e.g., transcript-protein, protein-phosphosite)
Identify concordant and discordant regulation patterns
Use weighted correlation network analysis (WGCNA) for module detection across layers
Pathway-based integration:
Map all omics data to common pathway frameworks
Perform integrated pathway enrichment analysis
Visualize multi-omics data on pathway maps using tools like PathVisio
Network-based approaches:
Construct molecular interaction networks incorporating all data types
Identify network modules and key regulators using algorithms like HotNet or PCSF
Infer causal relationships using Bayesian networks or directed random walks
Advanced computational methods:
Apply dimension reduction techniques (multi-omics factor analysis, MOFA)
Use tensor-based methods for three-dimensional data integration
Implement machine learning approaches (multi-view learning, deep neural networks)
Consider Bayesian data fusion for integrating heterogeneous data types
Biological interpretation:
Validation experiments:
Design targeted experiments to test hypotheses generated from integrated analysis
Verify key interactions using protein-protein interaction assays
Validate regulatory relationships through genetic perturbation
Confirm substrate relationships through degradation assays
When integrating data for At1g56610 specifically, pay attention to phosphorylation dynamics under osmotic stress conditions and temperature variations, building on previous research approaches in Arabidopsis , and connect these to potential SCF complex formation and substrate targeting.
Several cutting-edge technologies show promise for elucidating At1g56610 function:
Advanced protein structure determination:
AlphaFold2 and RoseTTAFold: Apply AI-based structure prediction to model At1g56610 alone and in complex with SCF components
Cryo-EM: Determine structures of entire SCF complexes containing At1g56610
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Map conformational changes upon substrate binding or phosphorylation
Single-molecule FRET: Study dynamic conformational changes in real-time
Next-generation genome editing:
Prime editing: Create precise modifications at the At1g56610 locus without double-strand breaks
Base editing: Introduce specific point mutations to test phosphorylation site function
CRISPR activation/interference: Modulate At1g56610 expression without genetic modification
Multiplexed CRISPR screens: Systematically test genetic interactions with At1g56610
Advanced proteomics approaches:
Proximity-dependent labeling: Apply TurboID or APEX2 fusions to identify transient interactors
Cross-linking mass spectrometry (XL-MS): Map protein interaction surfaces
Targeted proteomics: Develop parallel reaction monitoring assays for At1g56610 and interactors
Ubiquitin remnant profiling: Identify substrates by tracking ubiquitinated residues
Single-cell and spatial technologies:
Single-cell RNA-seq: Profile transcriptional consequences of At1g56610 activity at cellular resolution
Spatial transcriptomics: Map expression patterns in tissue context
Light-sheet microscopy: Track At1g56610 dynamics in living tissues
Protein correlation profiling: Map protein complex dynamics across subcellular compartments
Systems and synthetic biology approaches:
Optogenetic control: Engineer light-controlled versions of At1g56610 for temporal regulation
Synthetic circuits: Reconstruct At1g56610 regulatory networks in heterologous systems
Metabolic flux analysis: Connect At1g56610 function to physiological outputs
Multi-scale modeling: Integrate molecular, cellular, and organismal-level data
Similar to approaches used for glycoengineering recombinant proteins and methodologies employed for molecular characterization in Arabidopsis , these technologies could provide comprehensive insights into At1g56610 function, particularly how its phosphorylation status affects its roles in plant stress responses and development.
Understanding At1g56610 function could significantly impact crop improvement strategies through several translational pathways:
Comparative genomics and crop engineering:
Identify At1g56610 orthologs in major crops using phylogenomic approaches
Determine conservation of phosphorylation sites and regulatory mechanisms
Engineer crop orthologs using CRISPR-based genome editing
Create phosphorylation site variants to modulate protein function
Stress response optimization:
Characterize how At1g56610 contributes to osmotic stress responses in Arabidopsis
Determine if modulating ortholog expression or phosphorylation affects drought tolerance
Engineer stress-inducible expression systems for precisely timed activation
Stack At1g56610-based modifications with other stress tolerance traits
Targeted breeding applications:
Develop molecular markers around orthologous loci for marker-assisted selection
Screen germplasm collections for natural variation in ortholog function
Identify superior alleles from wild relatives for introgression
Use genomic selection approaches incorporating functional data
Field validation and performance testing:
Design field trials to assess stress tolerance under realistic conditions
Measure physiological parameters across stress gradients
Analyze yield components and stability across environments
Evaluate potential trade-offs between stress tolerance and productivity
Integration with broader crop improvement strategies:
Combine protein engineering approaches with traditional breeding
Develop multi-trait improvement strategies addressing multiple stresses
Consider tissue-specific or developmental stage-specific interventions
Assess sustainability metrics and environmental impacts of engineered varieties
The transition from fundamental knowledge to applications should build on insights from temperature response studies and osmotic stress experiments in Arabidopsis , while also implementing recombinant protein production methodologies for functional verification in heterologous systems before crop implementation.
For comprehensive analysis of At1g56610, researchers should utilize these specialized resources:
Primary sequence and annotation databases:
TAIR (The Arabidopsis Information Resource): Provides curated gene models, functional annotations, and expression data specific to At1g56610
UniProt: Contains protein sequence, domain information, and curated functional data
Ensembl Plants: Offers genomic context, conservation, and variant information
1001 Genomes Project: Provides natural variation data across Arabidopsis ecotypes
Expression and co-expression resources:
Arabidopsis eFP Browser: Visualizes tissue-specific and condition-specific expression patterns
ATTED-II: Identifies co-expressed genes and potential functional associations
Genevestigator: Allows meta-analysis of expression across multiple experiments
TraVA (Transcriptome Variation Analysis): Explores expression variation across conditions
Protein interaction databases:
BioGRID: Curates protein-protein interactions from various experimental approaches
STRING: Provides predicted and known protein interactions
IntAct: Offers molecular interaction data with detailed experimental evidence
Arabidopsis Interactome: Contains systematically mapped protein interactions
Structural prediction tools:
AlphaFold DB: Provides predicted structures for Arabidopsis proteins
SWISS-MODEL: Enables homology modeling based on related structures
I-TASSER: Offers integrated structure prediction
MolProbity: Allows assessment of model quality
Specialized F-box protein resources:
PlantsUFO: Database dedicated to F-box proteins in plants
F-box protein family pages in TAIR: Collates family-specific information
Ubiquitination site prediction tools: Identifies potential substrate modification sites
PhosphAt: Database of plant protein phosphorylation sites with specific data for Arabidopsis
When analyzing phosphorylation data, researchers should integrate information from phosphoproteomic studies that have identified the VFS(ph)QATLVTLK site and consider methodological approaches used in previous Arabidopsis studies examining protein modifications under stress conditions.
For comprehensive characterization of novel F-box proteins like At1g56610:
Standardized Protocol Collection:
Biochemical characterization:
SCF complex reconstitution protocol:
Express and purify recombinant components (At1g56610, ASK1, CUL1, RBX1)
Verify complex formation through size exclusion chromatography
Confirm E3 ligase activity using in vitro ubiquitination assays
Test substrate specificity with candidate proteins
Phosphorylation analysis protocol:
Cellular localization and dynamics:
Subcellular localization protocol:
Generate fluorescent protein fusions preserving F-box functionality
Examine localization in stable transgenic lines and transient expression
Perform co-localization with organelle markers
Analyze dynamics during stress responses and cell cycle progression
Protein turnover analysis protocol:
Measure protein half-life using cycloheximide chase assays
Determine ubiquitination status using immunoprecipitation
Assess proteasome-dependence using MG132 treatment
Compare turnover of wild-type and phospho-variants
Genetic and phenotypic analysis:
CRISPR/Cas9 mutagenesis and phenotyping protocol:
Transcriptome analysis protocol:
Compare wild-type and mutant transcriptomes under relevant conditions
Identify differentially expressed genes and enriched pathways
Validate key targets using RT-qPCR
Correlate transcriptional changes with protein abundance
Substrate identification protocol:
Combine proximity labeling, co-immunoprecipitation, and differential proteomics
Validate candidates through direct interaction and ubiquitination assays
Perform genetic epistasis tests between F-box mutants and substrate mutants
Analyze substrate stability in F-box mutant backgrounds